[1] Wang YF, Zhang W, He KF, Liu B, Zhang L, Zhang WF, et al. Induction of autophagy-dependent cell death by the survivin suppressant YM155 in salivary adenoid cystic carcinoma. Apoptosis : an international journal on programmed cell death. 2014;19(4):748-58.
[2] Sasahira T, Kurihara M, Yamamoto K, Ueda N, Nakashima C, Matsushima S, et al. HuD promotes progression of oral squamous cell carcinoma. Pathobiology : journal of immunopathology, molecular and cellular biology. 2014;81(4):206-14.
[3] Thiagarajan S, Dhar H, Bhattacharjee A, Fatehi KS, Shah SB, Chaukar D, et al. Patterns of failure and outcomes in cT4 Oral squamous cell carcinoma (OSCC) undergoing upfront surgery in comparison to Neo-Adjuvant Chemotherapy (NACT) followed by surgery: A Matched Pair analysis. Oral oncology. 2019;100:104455.
[4] Kuo YY, Jim WT, Su LC, Chung CJ, Lin CY, Huo C, et al. Caffeic Acid phenethyl ester is a potential therapeutic agent for oral cancer. International journal of molecular sciences. 2015;16(5):10748-66.
[5] Zhang L, Zhang W, Wang YF, Liu B, Zhang WF, Zhao YF, et al. Dual induction of apoptotic and autophagic cell death by targeting survivin in head neck squamous cell carcinoma. Cell death & disease. 2015;6:e1771.
[6] Keshavarzi M, Darijani M, Momeni F, Moradi P, Ebrahimnejad H, Masoudifar A, et al. Molecular Imaging and Oral Cancer Diagnosis and Therapy. Journal of cellular biochemistry. 2017;118(10):3055-60.
[7] Xu GQ, Li LH, Wei JN, Xiao LF, Wang XT, Pang WB, et al. Identification and profiling of microRNAs expressed in oral buccal mucosa squamous cell carcinoma of Chinese hamster. Scientific reports. 2019;9(1):15616.
[8] Taulli R, Loretelli C, Pandolfi PP. From pseudo-ceRNAs to circ-ceRNAs: a tale of cross-talk and competition. Nature structural & molecular biology. 2013;20(5):541-3.
[9] Zhao ZJ, Shen J. Circular RNA participates in the carcinogenesis and the malignant behavior of cancer. RNA biology. 2017;14(5):514-21.
[10] Li X, Yang L, Chen LL. The Biogenesis, Functions, and Challenges of Circular RNAs. Molecular cell. 2018;71(3):428-42.
[11] Lasda E, Parker R. Circular RNAs: diversity of form and function. RNA. 2014;20(12):1829-42.
[12] Wilusz JE. A 360 degrees view of circular RNAs: From biogenesis to functions. Wiley interdisciplinary reviews RNA. 2018;9(4):e1478.
[13] Chen LL, Yang L. Regulation of circRNA biogenesis. RNA biology. 2015;12(4):381-8.
[14] Li Y, Dong Y, Huang Z, Kuang Q, Wu Y, Li Y, et al. Computational identifying and characterizing circular RNAs and their associated genes in hepatocellular carcinoma. PloS one. 2017;12(3):e0174436.
[15] Dong Y, He D, Peng Z, Peng W, Shi W, Wang J, et al. Circular RNAs in cancer: an emerging key player. Journal of hematology & oncology. 2017;10(1):2.
[16] Xia X, Li X, Li F, Wu X, Zhang M, Zhou H, et al. A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by competing with active phosphoinositide-dependent Kinase-1. Molecular Cancer. 2019;18(1).
[17] Barbagallo D, Caponnetto A, Brex D, Mirabella F, Barbagallo C, Lauretta G, et al. CircSMARCA5 Regulates VEGFA mRNA Splicing and Angiogenesis in Glioblastoma Multiforme Through the Binding of SRSF1. Cancers. 2019;11(2).
[18] Xu J-Z, Shao C-C, Wang X-J, Zhao X, Chen J-Q, Ouyang Y-X, et al. circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis. Cell death & disease. 2019;10(3).
[19] Wang L, Wei Y, Yan Y, Wang H, Yang J, Zheng Z, et al. CircDOCK1 suppresses cell apoptosis via inhibition of miR196a5p by targeting BIRC3 in OSCC. Oncology reports. 2018;39(3):951-66.
[20] Mahakian LM, Farwell DG, Zhang H, Seo JW, Poirier B, Tinling SP, et al. Comparison of PET imaging with 64Cu-liposomes and 18F-FDG in the 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch model of oral dysplasia and squamous cell carcinoma. Molecular imaging and biology. 2014;16(2):284-92.
[21] I. R. Kramer, R. B. Lucas, J. J. Pindborg and L. H. Sobin. Definition of leukoplakia and related lesions: An aid to studies on oral precancer. Oral Surgery, Oral Medicine, Oral Pathology 46(518) (1978)539–537, 539.
[22] Zhang X, Zhou J, Xue D, Li Z, Liu Y, Dong L. MiR-515-5p acts as a tumor suppressor via targeting TRIP13 in prostate cancer. International journal of biological macromolecules. 2019;129:227-32.
[23] Qu S, Yang X, Li X, Wang J, Gao Y, Shang R, et al. Circular RNA: A new star of noncoding RNAs. Cancer Lett. 2015;365(2):141-8.
[24] Wang X, Chang K, Gao J, Wei J, Xu G, Xiao L, et al. MicroRNA-504 functions as a tumor suppressor in oral squamous cell carcinoma through inhibiting cell proliferation, migration and invasion by targeting CDK6. The International Journal of Biochemistry & Cell Biology. 2019:105663.
[25] Chen Y, Song Y, Yu Y, Cheng W, Tong X. miRNA-10a promotes cancer cell proliferation in oral squamous cell carcinoma by upregulating GLUT1 and promoting glucose metabolism. Oncology Letters. 2019;17(6):5441-6.
[26] Kong Y, feng Y, YY X, liu S, XG L. LncRNA LUCAT1 promotes rowth, migration, and invasion of oral squamous cell carcinoma by upregulating PCNA. European review for medical and pharmacological sciences. 2019;23(11):4770-6.
[27] Chew CL, Conos SA, Unal B, Tergaonkar V. Noncoding RNAs: Master Regulators of Inflammatory Signaling. Trends Mol Med. 2018;24(1):66–84. doi:10.1016/j.molmed.2017.11.003
[28] Kulcheski FR, Christoff AP, Margis R. Circular RNAs are miRNA sponges and can be used as a new class of biomarker. Journal of Biotechnology. 2016;238:42-51.
[29] Ryu J, Kwon DH, Choe N, Shin S, Jeong G, Lim YH, et al. Characterization of Circular RNAs in Vascular Smooth Muscle Cells with Vascular Calcification. Molecular therapy Nucleic acids. 2019;19:31-41.
[30] Ouyang SB, Wang J, Zhao SY, Zhang XH, Liao L. CircRNA_0109291 regulates cell growth and migration in oral squamous cell carcinoma and its clinical significance. Iran J Basic Med Sci. 2018;21(11):1186–1191. doi:10.22038/IJBMS.2018.30347.7313
[31] Yang J, Zhu D, Liu S, Shao M, Liu Y, Li A, et al. Curcumin enhances radiosensitization of nasopharyngeal carcinoma by regulating circRNA network. Molecular carcinogenesis. 2019.
[32] Yuan DM, Ma J and Fang WB. Identification of non-coding RNA regulatory networks in pediatric acute myeloid leukemia reveals circ-0004136 could promote cell proliferation by sponging miR-142. Eur Rev Med Pharmacol Sci. 2019;23(21):9251-9258.
[33] Mendell JT, Olson EN. MicroRNAs in stress signaling and human disease. Cell. 2012;148(6):1172-87.
[34] Rong D, Sun H, Li Z, Liu S, Dong C, Fu K, et al. An emerging function of circRNA-miRNAs-mRNA axis in human diseases. Oncotarget. 2017;8(42):73271-73281.
[35] Greene J, Baird AM, Brady L, Lim M, Gray SG, McDermott R, et al. Circular RNAs: Biogenesis, Function and Role in Human Diseases. Frontiers in molecular biosciences. 2017;4:38.
[36] Yang G, Zhang Y, Yang J. Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Gastric Carcinoma using Bioinformatics Analysis. Medical Science Monitor. 2019;25:8777-96.
[37] Zhu X, Shao P, Tang Y, Shu M, Hu WW, Zhang Y. hsa_circRNA_100533 regulates GNAS by sponging hsa_miR_933 to prevent oral squamous cell carcinoma. Journal of cellular biochemistry. 2019.
[38] Gao L, Zhao C, Li S, Dou Z, Wang Q, Liu J, et al. circ-PKD2 inhibits carcinogenesis via the miR-204-3p/APC2 axis in oral squamous cell carcinoma. Molecular carcinogenesis. 2019.
[39] Sudakin V,Chan GK,Yen TJ.Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. [J].2001,5(5).; 40 Tipton AR,Tipton M,Yen T,etc.Closed MAD2 (C-MAD2) is selectively incorporated into the mitotic checkpoint complex(MCC).[J].2011,21(21).
[40] Kurita K, Maeda M, Mansour MA, et al. TRIP13 is expressed in colorectal cancer and promotes cancer cell invasion. Oncol Lett. 2016;12(6):5240–5246. doi:10.3892/ol.2016.5332
[41] Kurita K, Maeda M, Mansour MA, et al. TRIP13 is expressed in colorectal cancer and promotes cancer cell invasion. Oncol Lett. 2016;12(6):5240–5246. doi:10.3892/ol.2016.5332
[42] Kass EM,Jasin M.Collaboration and competition between DNA double-strand break repair pathways.[J].2010,17(17).
[43] Holloman, W.K.Unraveling the mechanism of BRCA2 in homologous ecombination[J].2011,7(7).
[44] Zhou,W.,Yang,etc.NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associate with Poor Prognosis in Myeloma and Other Cancers[J].2013,1(1).
[45] Zhou XY and Shu XM. TRIP13 promotes proliferation and invasion of epithelial ovarian cancer cells through Notch signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23(2):522-529.
[46] Yoshida R, Ito T, Hassan WA, Nakayama H. Notch1 in oral squamous cell carcinoma. Histol Histopathol. 2017;32(4):315–323. doi:10.14670/HH-11-821
[47] Lv L, Wang Q, Yang Y, Ji H. MicroRNA‑495 targets Notch1 to prohibit cell proliferation and invasion in oral squamous cell carcinoma. Mol Med Rep. 2019;19(1):693–702. doi:10.3892/mmr.2018.9616
[48] Fillies T, Woltering M, Brandt B, et al. Cell cycle regulating proteins p21 and p27 in prognosis of oral squamous cell carcinomas. Oncol Rep. 2007;17(2):355–359.
[49] Yin D, Lu X, Su J, et al. Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression. Mol Cancer. 2018;17(1):92. Published 2018 May 24. doi:10.1186/s12943-018-0836-7
[50] Xu J, Wang Z, Lu W, et al. EZH2 promotes gastric cancer cells proliferation by repressing p21 expression. Pathol Res Pract. 2019;215(6):152374. doi:10.1016/j.prp.2019.03.003
[51] Zhang M, Li J, Wang L, et al. Prognostic significance of p21, p27 and survivin protein expression in patients with oral squamous cell carcinoma. Oncol Lett. 2013;6(2):381–386. doi:10.3892/ol.2013.1381
[52] Su W, Sun S, Wang F, Shen Y, Yang H. Circular RNA hsa_circ_0055538 regulates the malignant biological behavior of oral squamous cell carcinoma through the p53/Bcl-2/caspase signaling pathway. Journal of translational medicine. 2019;17(1):76.
[53] Chen L, Zhang S, Wu J, Cui J, Zhong L, Zeng L, et al. Retraction Note: circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family. Oncogene. 2019.
[55] Huang MS, Liu JY, Xia XB, Liu YZ, Li X, Yin JY, et al. Hsa_circ_0001946 Inhibits Lung Cancer Progression and Mediates Cisplatin Sensitivity in Non-small Cell Lung Cancer via the Nucleotide Excision Repair Signaling Pathway. Frontiers in oncology. 2019;9:508.
[56] Sang Y, Chen B, Song X, Li Y, Liang Y, Han D, et al. circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer. Molecular therapy : the journal of the American Society of Gene Therapy. 2019.